Skip to content

Non-invasive Left-sided Cervical Vagus Nerve Stimulation for Atrioventricular Reentrant Tachycardia

Non-invasive Left-sided Cervical Vagus Nerve Stimulation for Atrioventricular Reentrant Tachycardia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06219343
Enrollment
10
Registered
2024-01-23
Start date
2023-01-10
Completion date
2024-12-30
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Reentrant Tachycardia

Keywords

non-invasive, vagus nerve stimulation, rapid return rhythm

Brief summary

The goal of this Interventional clinical trials in atrioventricular reentrant tachycardia patients. The main question it aims to answer whether non-invasive vagus nerve stimulation could be effective in restoring rhythm. Patients will receive non-invasive vagus nerve electrical stimulation under catheter evoked and cardiac monitoring to observe their heart rhythm changes.

Detailed description

Participants will be treated with non-invasive electrical stimulation of the left vagus nerve in the neck. After routine induction of atrioventricular reentrant tachycardia prior to radiofrequency ablation, the electrode patch was placed on the patient's left cervical vagal body surface localization, i.e., between the sternocleidomastoid muscle and the trachea where the left common carotid artery pulsation could be palpated, and resuscitation was performed using non-invasive electrical stimulation.

Interventions

Patient undergoes non-invasive vagus nerve stimulation during tachycardia episodes to see if reentry is possible

Sponsors

Jingye Tai
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. The relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt) need to be met. 2. All need to be free of psychiatric abnormalities, verbal communication disorders, and have good compliance. 3. The patients and their families gave informed consent and signed the informed consent form.

Exclusion criteria

1. Does not meet the relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment of Supraventricular Tachycardia (svt). 2. Mental anomalies, verbal communication disorders, poor adherence 3. Those who do not consent to participate in this clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Whether the tachycardia is repetitive or not10minutesDetermining whether a tachycardia is reentrant on the basis of the ambulatory electrocardiogram

Secondary

MeasureTime frameDescription
Parameters leading to tachycardia resumption10minutesIntensity of electrical stimuli leading to tachycardia resumption

Countries

China

Contacts

Primary ContactAi-lan Chen
1228327958@qq.com13719198832

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026